medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Human&monoclonal&antibodies&block&the&binding&of&SARS7CoV72&spike&protein&
to&angiotensin&converting&enzyme&2&receptor&
!
Xiangyu!Chen1,11,!Ren!Li2,3,11,!Zhiwei!Pan1,11,!Chunfang!Qian4,11,!Yang!Yang1,!Renrong!
You5,!Jing!Zhao6,!Pinghuang!Liu5,!Leiqiong!Gao1,!Zhirong!Li1,!Qizhao!Huang7,!Lifan!
Xu1,! Jianfang! Tang1,! Qin! Tian1,! Wei! Yao1,! Li! Hu1,! Xiaofeng! Yan4,! Xinyuan! Zhou1,!
Yuzhang! Wu1,! Kai! Deng8,! Zheng! Zhang9,! Zhaohui! Qian10,12,! Yaokai! Chen4,12! &! Lilin!
Ye1,12!

1

Institute!of!Immunology,!PLA,!Third!Military!Medical!University,!Chongqing!400038,!

China!
2

State! Key! Laboratory! of! Veterinary! Biotechnology,! Harbin! Veterinary! Research!

Institute,! Chinese! Academy! of! Agricultural! Sciences,! Harbin,! Heilongjiang! 150001,!
China!
3

College!of!Veterinary!Medicine,!Northeast!Agricultural!University,!Harbin!Heilongjiang,!

150030,!China!
4

Chongqing!Public!Health!Medical!Center,!Chongqing!400038,!China!

5

Comparative! Immunology! Research! Center,! College! of! Veterinary! Medicine,! China!

Agricultural!University,!Beijing!100193,!China!
6

Biomedical! Analysis! Center,! Third! Military! Medical! University,! Chongqing! 400038,!

China!
7

Cancer! Center,! The! General! Hospital! of! Western! Theater! Command,! Chengdu,!

Sichuan!610083,!China!
8

Institute!of!Human!Virology,!Zhongshan!School!of!Medicine,!Sun!Yat^sen!University,!

Guangzhou,!Guangdong!510080,!China!
9

Institute! for! Hepatology,! National! Clinical! Research! Center! for! Infectious! Disease,!

Shenzhen!Third!People’s!Hospital,!Shenzhen,!Guangdong!518112,!China!
10

NHC!Key!laboratory!of!Systems!Biology!of!Pathogens,!Institute!of!Pathogen!Biology,!

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

Chinese! Academy! of! Medical! Sciences! and! Peking! Union! Medical! College,! Beijing!

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

100176,!China!
11

These!authors!contributed!equally!to!this!work!

12

Corresponding!authors:!Zhaohui!Qian!(zqian2013@sina.com),!Yaokai!Chen!

(yaokaichen@hotmail.com)!and!Lilin!Ye!(yelilinlcmv@tmmu.edu.cn)

&

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Abstract&
The! severe! acute! respiratory! syndrome! coronavirus! 2! (SARS^CoV^2)! has! caused! a!
global!pandemic!of!novel!corona!virus!disease!(COVID^19).!To!date,!no!prophylactic!
vaccines!or!approved!therapeutic!agents!are!available!for!preventing!and!treating!this!
highly! transmittable! disease.! Here! we! report! two! monoclonal! antibodies! (mAbs)!
cloned!from!memory!B!cells!of!patients!recently!recovered!from!COVID^19,!and!both!
mAbs!specifically!bind!to!the!spike!(S)!protein!of!SARS^CoV^2,!block!the!binding!of!
receptor! binding! domain! (RBD)! of! SARS^CoV^2! to! human! angiotensin! converting!
enzyme!2!(hACE2),!and!effectively!neutralize!S!protein^pseudotyped!virus!infection.!
These!human!mAbs!hold!the!promise!for!the!prevention!and!treatment!of!the!ongoing!
pandemic!of!COVID^19.! !
!

!

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Main&text&
According! to! World! Health! Organization! (WHO)! newly! updated! situation! report! on!
March! 18th,! 2020,! the! corona! virus! disease! 2019! (COVID^19)! pandemic! has!
confirmed!191,127!cases!and!claimed!7,807!deaths!worldwide1.!The!etiological!agent!
of!COVID^19!has!been!identified!as!a!novel!coronavirus,!the!severe!acute!respiratory!
syndrome!coronavirus!2!(SARS^CoV^2),!belonging!to!Sarbecovirus!subgenus!(genus!
Betacoronavirus,! family! Coronaviridae)! and! showing! 79.6%! and! 96.2%! sequence!
identity! in! nucleotide! to! SARS^CoV! and! a! bat! coronavirus! (BatCoV! RaTG13),!
respectively2^4.!Like!SARS^CoV!infection,!a!substantial!fraction!of!COVID^19!patients!
exhibits!severe!respiratory!symptoms!and!has!to!be!hospitalized!in!intensive!care!unit!
(ICU)5^8.! Although! the! mortality! rate! of! COVID^19! is! significantly! lower! than! that! of!
SARS^CoV! infection,! SARS^CoV^2! shows! much! higher! human^to^human!
transmission!rate,!rapidly!leading!to!a!global!pandemic!declared!by!WHO!on!March!
11th,!20209.! !
Currently,!there!are!no!approved!prophylactic!vaccines!or!therapeutic!drugs!that!are!
specific! to! COVID^19.! Blocking! monoclonal! antibodies! (mAbs),! due! to! their!
extraordinary!antigen!specificity,!are!one!of!the!best!candidates!for!neutralizing!virus!
infection10,!11.! Therefore,! identifying! and! cloning! blocking! mAbs! that! can! specifically!
target! surface! viral! proteins! to! block! the! viral! entry! to! host! cells! is! a! very! attractive!
approach!for!preventing!and!treating!COVID^19,!in!particular!when!effective!vaccines!
and!therapeutics!are!unavailable!in!the!outbreak!of!the!COVID^19!pandemic.!We!then!
sought! to! identify! and! clone! blocking! mAbs! from! the! memory! B! cell! repertoire! of!
recently!recovered!COVID^19!patients!to!prevent!the!entry!of!COVID^19!virus!to!the!
host!cells.!
Similar! to! SARS^CoV,! SARS^CoV^2! also! utilizes! highly! glycosylated! homotrimeric!
spike! (S)! protein! for! receptor! binding! and! virus! entry3,! 12^15.! The! S! protein! of!
SARS^CoV^2! consists! of! two! subunits,! S1! and! S2.! To! engage! host! cell! receptor!

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

human! angiotensin^converting! enzyme! 2! (hACE2),! shared! by! both! SARS^CoV! and!
SARS^CoV^2,! S! protein! undergoes! dramatic! conformational! changes! to! expose! the!
RBD! and! key! residues! for! receptor! binding.! S! protein! is! metastable,! and! binding! of!
RBD! to! hACE2! receptor! likely! leads! to! the! shedding! of! S1! protein! from! S2! protein,!
thus! promoting! S2^mediated! virus^host! membrane! fusion! and! virus! entry16^18.! Given!
the! critical! role! of! the! RBD! in! initiating! invasion! of! SARS^CoV^2! into! host! cells,! it!
becomes! a! vulnerable! target! for! neutralizing! antibodies.! Thus! far,! the! human! mAbs!
specifically!target!the!SARS^CoV^2!RBD^hACE2!interaction!have!not!been!reported,!
and! a! monoclonal! antibody! targeting! S1! made! from! immunized! transgenic! mice!
expressing! human! Ig! variable! heavy! and! light! chains! has! been! recently! shown! to!
neutralize! both! SARS^CoV^2! and! SARS^CoV! infection,! but! by! an! unknown!
mechanism!that!is!independent!of!the!blockade!of!RBD^hACE2!interaction19.!
Prior!to!cloning!SARS^CoV^2!RBD!specific!human!mAbs,!we!first!examined!whether!
patients! recently! recovered! from! COVID^19! had! mounted! anti^SARS^CoV^2! S1!
protein! IgG! antibodies! in! sera.! Among! 26! recovered! COVID^19! patients,! we! found!
that! the! majority! of! these! recruited! patients! were! able! to! produce! high! titers! of!
SARS^CoV^2!S1^specific!IgG!antibodies!and!only!3!patients!mounted!relatively!lower!
anti^S1! IgG! responses,! by! enzyme^linked! immunosorbent! assay! (ELISA)! (Fig.! 1a).!
Consistently,! we! also! found! that! SARS^CoV^2! RBD! specific! IgG! antibodies! were!
present! in! sera! of! all! patients! by! ELISA! (Fig.! 1b).! Next,! we! sought! to! investigate!
whether! RBD^specific! antibodies! in! patient! serum! can! block! the! binding! of!
SARS^CoV^2!RBD!to!hACE2.!To!this!end,!we!set!up!an!ELISA^based!inhibition!assay!
to!examine!the!blocking!function!of!these!antibodies.!We!noted!that!there!were!only!3!
out!of!26!patients!showed!effective!blockade!of!SARS^CoV^2!RBD!binding!to!hACE2!
(Fig.!1c).!Taken!together,!these!results!suggested!that!while!all!recovered!COVID^19!
patients! can! generate! anti^S1! and! anti^RBD! antibodies,! there! were! only! a! small!
fraction! of! these! antibodies! can! block! the! binding! of! RBD! to! hACE2! receptor.! This!
observation! may! be! explained! by! transient! and! dynamic! perfusion! conformational!

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

states!of!S!protein!that!provide!very!limited!window!for!the!immunogenic!epitopes!of!
RBD!exposure!to!specific!B!cells20.!
Next,!we!set!out!to!clone!human!monoclonal!antibodies!using!the!blood!samples!from!
three! COVID^19! recovered! patients,! of! which! their! sera! showed! potent! hACE2!
receptor! binding! inhibition.! To! this! end,! we! sorted! each! SARS^CoV^2! RBD! specific,!
IgG! class^switched! memory! B! cell! into! a! single! well! of! the! 96^well! microplates.!
Subsequently,!we!used!reverse!transcription!polymerase!chain!reaction!(RT^PCR)!to!
amplify!IgG!variable!heavy!chain!(VH)!and!light!chain!(VL)!from!each!single!memory!B!
cell.! After! cloning! both! VH! and! VL,! we! inserted! both! sequences! into! expression!
plasmids!that!encoding!constant!regions!of!human!IgG1!heavy!chain!and!light!chain!
(Fig.! 2a)21.! We! found! that! SARS^CoV^2! RBD! specific,! IgG^positive! memory! B! cells!
only! enriched! in! COVID^19! recovered! patients,! but! not! in! healthy! controls! (Fig.! 2b),!
suggesting! the! specificity! of! our! sorting! strategy.! The! representative! RT^PCR! and!
cloning!of!IgG1!heavy!chains!and!light!chains!to!expression!plasmids!were!shown!in!
Figure! 2c! and! 2d.! After! antibody! cloning,! we! acquired! 3! pairs! of! IgG! VHs! and! VLs!
inserted!expression!plasmids!and!the!CDR3!sequences!of!heavy!chains!were!shown!
in!

Figure!

2e!

(analyzed!

with!

IMGT!

browser,!

http://www.imgt.org/IMGT_vquest/analysis#sequence1_alj).!
Finally,!we!expressed!these!paired!plasmids!encoding!IgG!VH!and!VL!sequences!and!
named! these! three! mAbs! as! 311mab^31B5,! 311mab^32D4! and! 311mab^31B9,!
respectively.! We! first! examined! whether! these! human! mAbs! were! able! to! bind! to!
SARS^CoV^2!RBD!protein!by!ELISA.!The!results!showed!that!all!three!mAbs!strongly!
and! specifically! bind! to! the! RBD! protein! (Fig.! 3a).! Next,! we! tested! whether! these!
mAbs! can! block! the! interaction! between! SARS^CoV^2! RBD! and! hACE2.! We! found!
that! both! 311mab^31B5! and! 311mab^32D4! could! efficiently! block! SARS^CoV^2!
RBD^hACE2! interaction! (IC50=0.0332,! and! 0.0450! μg/ml,! respectively),! while!
311mab^31B9! clone! failed! to! inhibit! such! an! interaction! (Fig.! 3b).! The! 31B5^! and!

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

32D4^mediated! inhibition! of! RBD^hACE2! interaction! was! also! evidenced! by! flow!
cytometry!analysis!(Fig.!3c^e).!Furthermore,!we!determined!the!neutralization!of!these!
three! mAbs! using! a! SARS^CoV^2! S! pseudotyped! lentiviral! particle22.! In! line! with!
ELISA^! and! flow! cytometry^based! blockade! results,! both! 311mab^31B5! and!
311mab^32D4! effectively! neutralized! pseudovirus! entry! to! host! cells! ectopically!
expressing! hACE2! (IC50=0.0338,! and! 0.0698! μg/ml,! respectively).! As! expected,!
311mab^31B9!clone!failed!to!show!any!neutralization!activities!(Fig.!3f).!
In! conclusion,! we! have! successfully! cloned! two! human! blocking! mAbs! using!
SARS^CoV^2! RBD^specific! memory! B! cells! isolated! from! recovered! COVID^19!
patients.! These! two! mAbs! can! specifically! bind! to! SARS^CoV^2! RBD,! block! the!
interaction! between! SARS^CoV^2! RBD! and! hACE2! receptor,! and! lead! to! efficient!
neutralization! of! SARS^CoV^2! S! protein! pseudotyped! virus! infection.! Such! human!
anti^SARS^CoV^2!RBD^hACE2!blocking!mAbs!hold!great!promise!to!be!exploited!as!
specific!prophylactic!and!therapeutic!agents!against!ongoing!SARS^CoV^2!pandemic.!

!
Acknowledgement&
We! thank! Dr.! Jun! Huang! (University! of! Chicago)! for! discussion.! This! work! was!
supported!by!grants!from!the!National!Natural!Science!Fund!for!Distinguished!Young!
Scholars! (No.! 31825011! to! L.Y.)! and! the! Chongqing! Special! Research! Project! for!
Novel!Coronavirus!Pneumonia!Prevention!and!Control!(No.!cstc2020jscx^2!to!L.Y.o!No.!
cstc2020jscx^fyzx0074!to!Y.C.o!cstc2020jscx^fyzx0135!to!Y.C.).! !
&
Author&contributions&
X.C.,!R.L.,!Z.P.,!Q.C.,!Y.Y.,!R.Y.,!J.Z.,!L.G.,!Z.L,!Q.H.,!L.X.,!J.T.,!Q.T.,!W.Y.,!L.H.,!and!
X.Y.! performed! the! experiments.! L.Y.! designed! the! study,! analyzed! the! data! and!

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

wrote!the!paper!with!X.C.,!R.L.,!P.L.,!Y.C.,!Z.Q.,!X.Z.,!Y.W.,!K.D.!and!Z.Z.o!and!L.Y.,!
Y.K.!and!Z.Q.!supervised!the!study.!
!
Competing&interests&
The!authors!declare!no!competing!interests.!

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Materials&and&methods&
&
Human& samples.! The! 26! COVID^19! patients! enrolled! in! the! study! were! provided!
written! informed! consent.! Prior! to! blood! collection,! the! patients! were! clinically!
recovered! and! tested! negative! qPCR! for! SARS^CoV^2! virus! RNA.! Healthy! control!
subjects! were! 2! adult! participants! in! the! study.! The! study! received! IRB! approval! at!
Chongqing!Public!Health!Medical!Center!(2020^023^01^KY).!
&
PBMC&and&serum&collection.!Blood!samples!were!collected!in!cell!preparation!tubes!
with! or! without! sodium! citrate! (BD! Bioscience).! PBMCs! were! isolated! from! blood! in!
sodium! citrate! tubes! using! Ficoll! (TBD! Science),! washed! with! PBS! plus! 2%! FBS,!
suspended! in! cell! freezing! medium! (90%! FBS! plus! 10%! DMSO),! frozen! in! freezing!
chamber! first! at! ^80oC,! and! then! transferred! to! liquid! nitrogen.! Sera! were! collected!
from!blood!without!sodium!citrate!treatment!and!stored!in!aliquots!at!^80oC.! &
&
Single7cell& sorting& by& flow& cytometry.! For! B! cell! enrichment,! PBMCs! were! firstly!
stained!with!FITC^conjugated!anti^CD19!antibody!(Biolegend)!on!ice!for!30!min.!Then,!
FITC^CD19! stained! PBMCs! were! enriched! using! anti^FITC! MicroBeads! (Miltenyi!
Biotec)!by!following!manufacturer’s!protocol.!For!surface!staining,!the!enriched!CD19+!
B!cells!were!stained!with!biotin^conjugated!SARS^CoV^2!RBD!protein!(Sino!Biological,!
40592^V05H)! at! 4oC! for! 20! min,! followed! by! PE^Cy7^conjugated! streptavidin!
(eBioscience),! PE^conjugated! anti^CD20! antibody! (Biolegend),! APC^conjugated!
anti^human!IgG!(Fc)!(Biolegend),!APC^Cy7^conjugated!anti^CD3!antibody!(Biolegend),!
APC^Cy7^conjugated!

anti^CD14!

antibody!

(Biolegend),!

APC^Cy7^conjugated!

anti^CD56! antibody! (Biolegend)! and! APC^Cy7^conjugated! LIVE/DEAD! dye! (Life!
Technologies).! Cell! staining! was! performed! in! PBS! containing! 5%! mouse! serum!
(wt/vol).! For! cell! sorting,! the! stained! SARS^CoV^2! RBD^specific! IgG+! B! cells! were!
single^cell!sorted!into!96^well!plates!loaded!with!10!μl!catch!buffer!and!then!stored!at!

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

^80oC.!Catch!buffer:!to!1!ml!of!RNAase^free!water!(Tiangen!Biotech),!add!50!μl!1.5!M!
Tris!pH!8.8!(Beijing!Dingguo!Changsheng!Biotech)!and!40!μl!Rnasin!(NEB).! !
&
RT7PCR&and&PCR&cloning.!The!heavy!and!light!chain!genes!were!PCR!amplified!as!
previously!described21.!Briefly,!single^cell!sorted!plates!were!thawed!on!ice!and!added!
with! 15! μl! RT^PCR! master! mix! following! the! one! step! RT^PCR! kit! protocol! (Takara,!
RR057A)! with! primers! for! IgG! VH! and! IgG! VL.! RT^PCR! program:! 50oC! for! 30! min,!
94oC!for!2!min,!45!cycles!of!94oC!for!30!sec,!57oC!for!30!sec!and!72oC!for!1!min.!Then,!
RT^PCR!products!were!nested!PCR^amplified!with!nested!PCR!master!mix!following!
the!HS!DNA!polymerase!kit!protocol!(Takara,!TAK!R010)!with!primers!for!IgG!VH!or!
IgG!VL.!Nested!PCR!program:!98oC!for!4!min,!45!cycles!of!98oC!for!1!min,!57oC!for!1!
min!and!72oC!for!1!min.!Next,!heavy!and!light!chain!PCR!products!were!purified!and!
nuclease! digested! with! Age1^HF/Sal1^HF! (NEB)! and! Age1^HF/BsiW1^HF! (NEB),!
respectively.! The! digested! heavy! and! light! chain! genes! were! further! cloned! into!
human!IgG1!heavy!chain!and!light!chain!expression!vectors,!respectively.&
&
Transfection.!Human!embryonic!kidney!(HEK)!293T!cells!of!80^90%!confluent!in!the!
15!cm!tissue!culture!plate!were!transfected!with!master!mixture!containing!9!μg!heavy!
chain! plasmid,! 9! μg! light! chain! plasmid! and! 60! μl! TransIT^293! Transfection! reagent!
(Mirus).!The!culture!media!was!changed!to!basal!media!24!hours^post!transfection.!
Then,!the!culture!media!was!collected!from!the!plate!2!days!later.&
&
ELISA.! 50! ng! of! SARS^CoV^2! S1! protein! (Sino! Biological,! 40591^V08H)! or!
SARS^Cov2!RBD!protein!(Sino!Biological,!40592^V08B)!in!100!μl!PBS!per!well!was!
coated!on!ELISA!plates!overnight!at!4oC.!Then,!the!ELISA!plates!were!blocked!for!1!
hour! with! blocking! buffer! (5%! FBS! plus! 0.05%! Tween! 20).! Next,! mAbs! or! ten^fold!
diluted!patient!sera!were!added!to!each!well!in!100!μl!blocking!buffer!for!1!hour.!After!
washing!with!PBST,!the!bound!antibodies!were!incubated!with!anti^human!IgG!HRP!

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

detection! antibody! (Bioss! Biotech)! for! 30! min,! followed! by! washed! with! PBST,! then!
PBS!and!addition!of!TMB!(Beyotime).!The!ELISA!plates!were!allowed!to!react!for!5!
min! and! then! stopped! by! 1! M! HCl! stop! buffer.! The! optical! density! (OD)! value! was!
determined!at!450!nm.! &
&
ELISA7based& receptor7binding& inhibition& assay.& 200! ng! of! hACE2! protein! (Sino!
Biological,!10108^H08H)!in!100!μl!PBS!per!well!was!coated!on!ELISA!plates!overnight!
at!4oC.!Then,!the!ELISA!plates!were!blocked!for!1!hour!with!blocking!buffer!(5%!FBS!
plus! 0.05%! Tween! 20)o! meanwhile,! three^fold! serial! dilutions! of! mAbs! or! ten^fold!
diluted!patient!sera!were!incubated!with!optimal!dose!(based!on!EC50)!of!SARS^Cov2!
RBD!protein!(Sino!Biological,!40592^V05H)!for!1!hour.!Then,!the!incubated!mixtures!
were! added! to! ELISA! plates! and! allowed! to! develop! for! 30! min,! followed! by! PBST!
washing!and!anti^mouse!Fc!HRP!antibody!(Thermo!Fisher!Scientific).!Next,!the!ELISA!
plates! were! washed! with! PBST,! then! PBS! and! added! with! TMB! (Beyotime).! After! 5!
min,! the! ELISA! plates! were! stopped! and! determined! at! 450! nm.! The! half! maximal!
inhibitory! concentration! (IC50)! was! determined! by! using! 4^parameter! logistic!
regression.&
&
Flow& cytometry7based& receptor7binding& inhibition& assay.& 311mab! mAbs! or!
isotype! were! incubated! with! optimal! dose! (based! on! EC50)! of! SARS^Cov2! RBD!
protein! (Sino! Biological,! 40592^V05H)! for! 1! hour! at! RT.! Then,! the! mixtures! were!
incubated!with!10,000!hACE2^plasmid!transiently!transfected!293T!cells!for!40!min!on!
ice,! followed! by! stained! with! Alexa! Fluor! 647^conjugated! goat! anti^mouse! IgG!
(Biolegend)!and!APC^Cy7^conjugated!LIVE/DEAD!dye!(Life!Technologies).&
&
Pseudovirus&neutralization&assay.!Spike!protein!of!SARS^Cov^2!typed!pseudovirus!
was!produced!as!previously!described22.!Concisely,!HEK^293T!cells!were!transfected!
with! psPAX2,! pLenti^GFP! and! 2019^nCov! S! plasmids! by! using! TransIT^293!

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Transfection! reagent! (Mirus).! The! culture! media! was! changed! to! fresh! media! 12!
hours^post! transfection.! And! at! 64! hours! after! transfection,! supernatants! were!
harvested.!For!pseudovirus!neutralization!assay,!three^fold!serially!diluted!mAbs!were!
mixed! with! SARS^Cov^2! typed! pseudovirus! for! 1! hour.! Then,! the! mixture! was!
incubated!with!hACE2^expressing!HEK^293T!(hACE2/293T)!cells!overnight,!followed!
by! change! of! fresh! media.! At! 40! hours^post! incubation,! the! luciferase! activity! of!
infected!hACE2/293T!cells!were!detected!by!Dual^Luciferase!Reporter!Assay!System!
(Promega).! The! percent! of! infection! was! calculated! as! ratio! of! luciferase! value! with!
mAbs! to! that! without! mAbs.! The! half! maximal! inhibitory! concentration! (IC50)! was!
determined!by!using!4^parameter!logistic!regression.!
!

!

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Figure&legends&
&
Figure&1&ELISA&binding&and&blocking&assays&of&COVID719&patient&sera.!(a)&ELISA!
binding! assay! of! COVID^19! patient! sera! to! ELISA! plate! coating! of! SARS^CoV^2! S1!
protein.!(b)&ELISA!binding!assay!of!COVID^19!patient!sera!to!ELISA!plate!coating!of!
SARS^CoV^2! RBD! protein.& (c)! COVID^19! patient! serum^mediated! inhibition! of! the!
SARS^CoV^2! S1! protein! binding! to! hACE2! protein! by! ELISA.! NC,! negative! control.!
HD,!healthy!donor.! !
!
Figure& 2& Cloning& human& mAbs& from& single& SARS7Cov2& RBD7specific& IgG+&
memory& B& cells& of& three& recovered& patients& whose& sera& potentially& blocked&
RBD7hACE2&interaction.&(a)!An!overall!strategy!of!anti^SARS^CoV^2!RBD!mAbs.!(b)!
Flow! cytometry! analysis! of! SARS^CoV^2! RBD^specific! IgG+! B! cells! in! PBMCs! of!
healthy! donor! and! patient! XFQ.! (c)! Heavy! and! light! Ig^chain! encoding! segments! of!
SARS^CoV^2! RBD^specific! IgG+! B! cells! were! amplified! by! single^cell! RT^PCR.! (d)&
Endonuclease! digestion! of! IgG! VH! and! VL! inserts! in! the! plasmids.! (e)! CDR3!
sequences!of!heavy!chains.! !
!
Figure& 3& Characterization& of& mAbs& against& SARS7Cov2& RBD.& (a)! Specificity! of!
mAbs! (311mab^31B5,! ^32D4! and! ^31B9! clones)! to! SARS^CoV^2! RBD! protein! by!
ELISA.! (b)! ELISA! analysis! of! SARS^CoV^2! RBD^hACE2! interaction! inhibited! by!
311mab^31B5,!^32D4!and!^31B9!mAbs.!(c)!Flow!cytometry!analysis!of!SARS^CoV^2!
RBD^hACE2! interaction! inhibited! by! 311mab^31B5,! ^32D4! and! ^31B9! mAbs.& The!
numbers!adjacent!to!the!outlined!areas!indicate!the!percentages!of!anti^mouse!IgG+!
hACE2^plasmid! transiently! transfected! 293T! cells,! which! are! summarized! in! (d).& (e)&
Mean! fluorescence! intensity& of! Alexa! Fluor! 647! anti^mouse! IgG! in! anti^mouse! IgG+!
hACE2^plasmid!transiently!transfected!293T!cells.!(f)!Antibody^mediated!blocking!of!
luciferase^encoding!SARS^Cov^2!typed!pseudovirus!into!hACE2/293T!cells.!The!data!

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

are!representative!of!two!independent!experiments!with!three!replicates!per!group!(a,!
b,!d^fo!error!bars!in!a,!b,!d^f!indicate!the!SD).!
&

&

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

References&
1.!

World4Health4Organization.4 4
https://www.who.int/docs/default^source/coronaviruse/situation^reports/20200
318^sitrep^58^covid^19.pdf?sfvrsn=20876712_2.!2020.!

2.!

Wu,!F.,!et!al.,!A4new4coronavirus4associated4with4human4respiratory4disease4in4
China.!Nature,!2020.!579(7798):!p.!265^269.!

3.!

Zhou,!P.,!et!al.,!A4pneumonia4outbreak4associated4with4a4new4coronavirus4of4
probable4bat4origin.!Nature,!2020.!579(7798):!p.!270^273.!

4.!

Zhu,!N.,!et!al.,!A4Novel4Coronavirus4from4Patients4with4Pneumonia4in4China,4
2019.!N!Engl!J!Med,!2020.!382(8):!p.!727^733.!

5.!

Huang,!C.,!et!al.,!Clinical4features4of4patients4infected4with420194novel4
coronavirus4in4Wuhan,4China.!Lancet,!2020.!395(10223):!p.!497^506.!

6.!

Wang,!D.,!et!al.,!Clinical4Characteristics4of41384Hospitalized4Patients4With4
20194Novel4CoronavirusKInfected4Pneumonia4in4Wuhan,4China.!JAMA,!2020.!

7.!

Yang,!X.,!et!al.,!Clinical4course4and4outcomes4of4critically4ill4patients4with4
SARSKCoVK24pneumonia4in4Wuhan,4China:4a4singleKcentered,4retrospective,4
observational4study.!Lancet!Respir!Med,!2020.!

8.!

Chen,!N.,!et!al.,!Epidemiological4and4clinical4characteristics4of4994cases4of4
20194novel4coronavirus4pneumonia4in4Wuhan,4China:4a4descriptive4study.!
Lancet,!2020.!395(10223):!p.!507^513.!

9.!

World4Health4Organization.4
https://www.who.int/dg/speeches/detail/who^director^general^s^opening^remar
ks^at^the^media^briefing^on^covid^19^^^11^march^2020.!2020.!

10.!

Marston,!H.D.,!C.I.!Paules,!and!A.S.!Fauci,!Monoclonal4Antibodies4for4
Emerging4Infectious4Diseases4K4Borrowing4from4History.!N!Engl!J!Med,!2018.!
378(16):!p.!1469^1472.!

11.!

Saylor,!C.,!E.!Dadachova,!and!A.!Casadevall,!Monoclonal4antibodyKbased4
therapies4for4microbial4diseases.!Vaccine,!2009.!27&Suppl&6:!p.!G38^46.!

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

12.!

Jun!Lan,!J.G.,!Jinfang!Yu,!Sisi!Shan,!Huan!Zhou,!Shilong!Fan,!Qi!Zhang,!
Xuanling!Shi,!Qisheng!Wang,!Linqi!Zhang,!Xinquan!Wang,!Crystal4structure4of4
the42019KnCoV4spike4receptorKbinding4domain4bound4with4the4ACE24receptor.!
bioRxiv,!2020.!2020.02.19.956235Y&doi:&
https://doi.org/10.1101/2020.02.19.956235.!

13.!

Li,!F.,!Structure,4Function,4and4Evolution4of4Coronavirus4Spike4Proteins.!Annu!
Rev!Virol,!2016.!3(1):!p.!237^261.!

14.!

Li,!F.,!et!al.,!Structure4of4SARS4coronavirus4spike4receptorKbinding4domain4
complexed4with4receptor.!Science,!2005.!309(5742):!p.!1864^8.!

15.!

Yan,!R.,!et!al.,!Structural4basis4for4the4recognition4of4the4SARSKCoVK24by4
fullKlength4human4ACE2.!Science,!2020.!

16.!

Gui,!M.,!et!al.,!CryoKelectron4microscopy4structures4of4the4SARSKCoV4spike4
glycoprotein4reveal4a4prerequisite4conformational4state4for4receptor4binding.!
Cell!Res,!2017.!27(1):!p.!119^129.!

17.!

Kirchdoerfer,!R.N.,!et!al.,!PreKfusion4structure4of4a4human4coronavirus4spike4
protein.!Nature,!2016.!531(7592):!p.!118^21.!

18.!

Wrapp,!D.,!et!al.,!CryoKEM4structure4of4the42019KnCoV4spike4in4the4prefusion4
conformation.!Science,!2020.!367(6483):!p.!1260^1263.!

19.!

Chunyan!Wang,!W.L.,!Dubravka!Drabek,!Nisreen!M.A.!Okba,!Rien!van!
Haperen,!Albert!D.M.E.!Osterhaus,!Frank!J.M.!van!Kuppeveld,!Bart!L.!
Haagmans,!Frank!Grosveld,!Berend^Jan!Bosch,!A4human4monoclonal4
antibody4blocking4SARSKCoVK24infection.!bioRxiv,!2020.!2020.03.11.987958Y&
doi:&https://doi.org/10.1101/2020.03.11.987958.&

20.!

Pallesen,!J.,!et!al.,!Immunogenicity4and4structures4of4a4rationally4designed4
prefusion4MERSKCoV4spike4antigen.!Proc!Natl!Acad!Sci!U!S!A,!2017.!114(35):!
p.!E7348^E7357.!

21.!

Smith,!K.,!et!al.,!Rapid4generation4of4fully4human4monoclonal4antibodies4
specific4to4a4vaccinating4antigen.!Nat!Protoc,!2009.!4(3):!p.!372^84.!

medRxiv preprint doi: https://doi.org/10.1101/2020.04.06.20055475; this version posted April 11, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

22.!

Xiuyuan!Ou,!Y.L.,!Xiaobo!Lei,!Pei!Li,!Dan!Mi,!Lili!Ren,!Li!Guo,!Ruixuan!Guo,!
Ting!Chen,!Jiaxing!Hu,!Zichun!Xiang,!Zhixia!Mu,!Xing!Chen,!Jieyong!Chen,!
Keping!Hu,!Qi!Jin,!Jianwei!Wang,!Zhaohui!Qian,!Characterization4of4spike4
glycoprotein4of42019K4nCoV4on4virus4entry4and4its4immune4crossK4reactivity4with4
spike4glycoprotein4of4SARSKCoV.!Nature!Communications,!2020.!
Doi:10.21203/rs.2.24016/v1.!

!

N
C
H
D
LZ
S
ZS
C X
M
YZF
XZ Y
M
LL
C
D
W
SG
XF L
Q
C
LF
ZM
ZC
L
ZY
X
X
B H
ZM
G
XP
G
W F
YT
L
W H
SH
Z
Q N
XP
L
ZX J
X
YZ
LD
Z

OD Value (450 nm)
N
C
H
D
LZ
S
ZS
C X
M
YZF
XZ Y
M
LL
C
D
W
SG
XF L
Q
C
LF
ZM
ZC
L
ZY
X
X
B H
ZM
G
XP
G
W F
YT
L
W H
SH
Z
Q N
XP
L
ZX J
X
YZ
LD
Z

OD Value (450 nm)
N
C
H
D
LZ
S
ZS
C X
M
YZF
XZ Y
M
LL
C
D
W
SG
XF L
Q
C
LF
ZM
ZC
L
ZY
X
XH
B
ZM
G
XP
G
W F
YT
L
W H
SH
Z
Q N
XP
L
ZX J
X
YZ
LD
Z

OD Value (450 nm)

Figure'1

a
SARS-CoV-2 S1 binding assay

3.0

2.5

2.0

1.5

1.0

0.5

0.0

b
SARS-CoV-2 RBD binding assay

2.5

2.0

1.5

1.0

0.5

0.0

c

RBD-hACE2 binding inhibition assay

2.0

1.5

1.0

0.5

0.0

Figure'2
a

b

PE0CD20

0%

1.68%

FITC0CD19

PE0CD20

Gated& on&live&CD19+CD32 CD142 CD562

c

RT0PCR

IgG'VH

100

100

d

Endonuclease'digestion
5000
3000
2000
1500
1000
750
500
250
100

Vector

IgG'VH
inserts

DNA'marker'
(bp)

DNA'marker'
(bp)
2000
1000
750
500
250

Gated& on&live&CD19+CD32 CD142 CD562

DNA'marker'
(bp)

DNA'marker'
(bp)
2000
1000
750
500
250

PE0Cy70
SARS0CoV02'RBD

APC0IgG

7.02%

Patient'XFQ

APC0IgG

PE0Cy70
SARS0CoV02'RBD

Healthy'donor

IgG'VL

5000
3000
2000
1500
1000
750
500
250
100

Vector

IgG'VL
inserts

e

0.87%

FITC0CD19

Figure'3
a

b
RBD-hACE2 interation inhibition assay

RBD binding assay

31B5
32D4
31B9
Isotype

150

(100 - inhibition) %

OD Value (450 nm)

1.5

1.0

0.5

0.0

31B5

32D4

31B9

100

50

0
0.0001

Isotype

0.001

0.01

0.1

1

mAb concentration (µg/ml)

c

Frequency
831B9

32D4

Anti-mouse IgG+
(% of hACE2/293T)

31B5

3.40%

FSC0W

2.93%

6
4
2

32D4

f

31B9

Isotype

Anti-mouse IgG MFI (×103)

MFI
Pseudovirus neutralization assay

8

Infection (%)

150

31B5
32D4
31B9
Isotype

6

1004
2

50

0

31B5

0
0.001

32D4

0.01

31B9

0.1

2

31B5

32D4

Isotype

1

mAb concentration (µg/ml)

10

31B9

Isotype

MFI
Anti-mouse IgG MFI (×103)

Anti-mouse IgG+
(% of hACE2/293T)

8

31B5

5.80%

e

Frequency

0

5.30%

4

0

Alexa' Fluor'6740anti0mouse' IgG

d

6

Isotype

8
6
4
2
0

31B5

32D4

31B9

Isotype

